This is just an idea. But after reading numerous reports involving the influence big pharma have over gps and more significantly for us, over CCG's. Perhaps we are lobbying the wrong people. Should we perhaps start to lobby Concordia to promote liothyronine to CCGs and gps on our behalf ?
One of the reports I read involved the practice of changing meds from branded to generic so they could bump the price up. A drug for Parkinson's - Symmetrel, is reported as going from £5 to £130 in the last 18 months.
A drug used for epilepsy branded as Epanutin was unbranded in 2013, phentyoin sodium. The cost to the NHS has shot up from £2.3 million in 2013 to £50 million.
This drug is not on the governments list to be removed due to cost. Because it is seen as essential. As we know t3 is.
An organisation called No Free Lunch, founded by Dr Bob Goodman in the US and by Dr Spence in the UK aims to 'challenge the culture of big Pharma and bring awareness of of the medication we use today'. Dr Margaret McCarthy ( gp and medical journalist ) agrees 'many pharma companies do not publish all their research and as a result the evidence can be skewed'. But these people unfortunately are in the minority.
If we lobby Concordia with all the positive evidence proving t3 works well for many people. Including evidence that it protects the heart. Perhaps we can persuade them to effectively do the work on our behalf ? They see the profits that can be made and are in a position to convince the medical profession of its benefits. ? ? ?